ghk-cu subcutaneous injection human trial Frontiers GHK-Cu Dosing: 1.7mg/Day Injectable (2026)
Description
doi: 10.1182/blood-2017-07-797050
This means that anything that could be a named drug, like BPC-157, would need full drug approval before a compounding pharmacy can legally compound it for human use
An atlas of genetic associations in UK Biobank
Individuals with copper metabolism disorders, kidney disease, or those taking medications affecting copper absorption should consult a healthcare provider before use
